Investigating the Role of Reticulon 3 in Modulating Dengue Virus Exosome Loading

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 486935

Grant search

Key facts

  • Disease

    Dengue
  • start year

    2023
  • Known Financial Commitments (USD)

    $4,405.32
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Gwanyama Bella
  • Research Location

    Canada
  • Lead Research Institution

    INRS - (Québec, QC)
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Dengue fever is a mosquito-borne viral illness caused by the Dengue virus (DENV) that affects millions of people around the world and is a potential pandemic threat. Exosomes, which are vesicles secreted by infected cells, play an important role in DENV infection and disease pathogenesis. Reticulon 3 (RTN3) is a recently discovered membrane protein that is thought to play a role in regulating Flavivirus exosome loading, especially during hepatitis C virus (HCV) infection. The goal of this project is to study the role of RTN3 in modulating DENV exosome loading during disease pathogenesis. To achieve this goal, we will use a combination of cell and virus culture, molecular biology techniques, and Nano Flow Cytometry to study RTN3-mediated DENV exosome loading. Specifically, we will use RT-qPCR, western blotting, and flow cytometry to characterize exosomes secreted by infected cells. We will also assess the effects of RTN3 knockdown and overexpression on DENV exosome loading. This summer student project is particularly important since DENV is a re-emerging virus with pandemic potential and DENV exosomes can compromise vaccines and therapeutics. Understanding how RTN3 modulates DENV exosome loading will provide valuable information for developing effective DENV vaccines and therapeutics.